We preliminarily revealed that HF may suppress the activation of inflammatory macrophages by downregulating IL-17 C, p-NF-κB, and MMP9 in the IL-17 signaling pathway, providing a strong theoretical and experimental basis for follow-up research and clinical application of HF in treating the immunoinflammatory response of RA. This evidence concerns the gene MMP9 and hydrops fetalis.